The 10,000-step target was invented by a Japanese pedometer company in 1965. The science says 7,000–8,000 steps per day is where the mortality curve flattens — and the benefits are dose-dependent up to that point.
The 10,000-step target has no scientific origin. It was coined by the Japanese pedometer manufacturer Yamasa in 1965 as a marketing slogan for their 'Manpo-kei' (10,000 steps meter) device. The number was chosen because the kanji character for 10,000 (万) resembles a walking figure — not because of any physiological threshold. For six decades, this marketing number has been repeated as health advice. The actual science tells a more nuanced story.
A 2022 meta-analysis in JAMA Internal Medicine pooled data from 15 studies covering 47,471 adults and found that all-cause mortality risk decreased progressively with step count up to approximately 8,000–10,000 steps per day, with the steepest decline occurring between 2,000 and 7,000 steps. Critically, the benefit was dose-dependent: every 1,000 additional steps per day was associated with a 10–15% reduction in all-cause mortality risk. The curve flattened above 8,000–10,000 steps — meaning there is little additional mortality benefit from walking 15,000 steps versus 10,000 steps.
A separate 2020 JAMA study of 4,840 adults from the NHANES cohort found that those taking 8,000 steps per day had a 51% lower risk of all-cause mortality compared to those taking 4,000 steps, and those taking 12,000 steps had a 65% lower risk. The step intensity (cadence) did not significantly modify the association after adjusting for total steps — suggesting that it is the volume of walking, not the pace, that drives the mortality benefit.
Key finding
7,000–8,000 steps per day is the evidence-based target. Below 5,000 steps is associated with significantly elevated mortality risk. Above 10,000 steps provides diminishing returns on all-cause mortality, though it may have additional benefits for cardiovascular fitness and weight management.
Vitaei verdict
Walking is the single most accessible longevity intervention with the strongest population-level evidence. The target is 7,000–8,000 steps per day — not 10,000. Every 1,000 additional steps from a low baseline reduces mortality risk by 10–15%. If you do nothing else, walk.